McKesson Corporation has recalled 42 units of Cabtreo (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel (1.2%/0.15%/3.1%) because it was stored at room temperature instead of being refrigerated as required. The recall affects 50g tubes from lot 7001796 with an expiration date of May 31, 2025. This medication is used for the treatment of acne, and improper storage may have compromised its stability.
Exposing the medication to room temperature instead of constant refrigeration can cause the ingredients to degrade. This could make the gel less effective at treating skin conditions or potentially cause skin irritation.
You have 2 options:
Recall #: D-0347-2024. Distributed by Bausch Health US, LLC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.